Influence of andrographolide on the pharmacokinetics of warfarin in rats

References

• Aromdee C. 2014. Andrographolide: progression in its modifications and applications – a patent review (2012–2014). Expert Opin Ther Pat. 24:1129–1138.
   PubMed Web of Science ®Google Scholar
• Bala MM, Celinska-Lowenhoff M, Szot W, Padjas A, Kaczmarczyk M, Swierz MJ, Undas A. 2017. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Cochrane Database Syst Rev. 10:CD012169.
   PubMed Web of Science ®Google Scholar
• Balap A, Atre B, Lohidasan S, Sinnathambi A, Mahadik K. 2016. Pharmacokinetic and pharmacodynamic herb-drug interaction of Andrographis paniculata (Nees) extract and andrographolide with etoricoxib after oral administration in rats. J Ethnopharmacol. 183:9–17.
   PubMed Web of Science ®Google Scholar
• Balap A, Lohidasan S, Sinnathambi A, Mahadik K. 2017. Herb-drug interaction of Andrographis paniculata (Nees) extract and andrographolide on pharmacokinetic and pharmacodynamic of naproxen in rats. J Ethnopharmacol. 195:214–221.
   PubMed Web of Science ®Google Scholar
• Chen W, Su H, Feng L, Zheng X. 2016. Andrographolide suppresses preadipocytes proliferation through glutathione antioxidant systems abrogation. Life Sci. 156:21–29.
   PubMed Web of Science ®Google Scholar
• Choi S, Oh DS, Jerng UM. 2017. A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin. PLoS One. 12:e0182794.
   PubMed Web of Science ®Google Scholar
• Chua LS. 2014. Review on liver inflammation and antiinflammatory activity of Andrographis paniculata for hepatoprotection. Phytother Res Ptr. 28:1589–1598.
   PubMed Web of Science ®Google Scholar
• Chua YT, Ang XL, Zhong XM, Khoo KS. 2015. Interaction between warfarin and Chinese herbal medicines. Singapore Med J. 56:11–18.
   PubMed Web of Science ®Google Scholar
• Di Minno A, Frigerio B, Spadarella G, Ravani A, Sansaro D, Amato M, Kitzmiller JP, Pepi M, Tremoli E, Baldassarre D. 2017. Old and new oral anticoagulants: food, herbal medicines and drug interactions. Blood Rev. 31:193–203.
   PubMed Web of Science ®Google Scholar
• FDA. 2013. Guidance for industry, bioanalytical method validation.
   Google Scholar
• Friberg L, Oldgren J. 2017. Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation. Open Heart. 4:e000682.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, von Moltke LL. 2005. Interaction of warfarin with drugs, natural substances, and foods. J Clinic Pharmacol. 45:127–132.
   PubMed Web of Science ®Google Scholar
• Gupta S, Mishra KP, Ganju L. 2017. Broad-spectrum antiviral properties of andrographolide. Archives Virol. 162:611–623.
   PubMed Web of Science ®Google Scholar
• Hovhannisyan AS, Abrahamyan H, Gabrielyan ES, Panossian AG. 2006. The effect of Kan Jang extract on the pharmacokinetics and pharmacodynamics of warfarin in rats. Phytomed Int J Phytother Phytopharmacol. 13:318–323.
   PubMed Web of Science ®Google Scholar
• Jia Y, Liu J, Xu J. 2018. Influence of grapefruit juice on pharmacokinetics of triptolide in rats grapefruit juice on the effects of triptolide. Xenobiotica. 48:407–411.
   Web of Science ®Google Scholar
• Lee NJ, Fermo JD. 2006. Warfarin and royal jelly interaction. Pharmacotherapy. 26:583–586.
   PubMed Web of Science ®Google Scholar
• Li H, Zhang C, Fan R, Sun H, Xie H, Luo J, Wang Y, Lv H, Tang T. 2016. The effects of Chuanxiong on the pharmacokinetics of warfarin in rats after biliary drainage. J Ethnopharmacol. 193:117–124.
   PubMed Web of Science ®Google Scholar
• Lim JC, Chan TK, Ng DS, Sagineedu SR, Stanslas J, Wong WS. 2012. Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer. Clinic Experimental Pharmacol Amp; Physiol. 39:300–310.
   PubMed Web of Science ®Google Scholar
• Liu S, Li X, Shi Q, Hamilton M, Friend K, Zhao Y, Horblyuk R, Hede S, Shi L. 2018. Outcomes associated with warfarin time in therapeutic range among US veterans with nonvalvular atrial fibrillation. Curr Med Res Opin. 34:415–421.
   Web of Science ®Google Scholar
• Liu Y, Liu S, Shi Y, Qin M, Sun Z, Liu G. 2018. Effects of safflower injection on the pharmacodynamics and pharmacokinetics of warfarin in rats. Xenobiotica. 48:818–823.
   Web of Science ®Google Scholar
• Milic N, Milosevic N, Golocorbin Kon S, Bozic T, Abenavoli L, Borrelli F. 2014. Warfarin interactions with medicinal herbs. Nat Prod Commun. 9:1211–1216.
   PubMed Web of Science ®Google Scholar
• Nagata N, Yasunaga H, Matsui H, Fushimi K, Watanabe K, Akiyama J, Uemura N, Niikura R. 2017. Therapeutic endoscopy-related GI bleeding and thromboembolic events in patients using warfarin or direct oral anticoagulants: results from a large nationwide database analysis. Gut.
   PubMed Web of Science ®Google Scholar
• Norby FL, Bengtson LGS, Lutsey PL, Chen LY, MacLehose RF, Chamberlain AM, Rapson I, Alonso A. 2017. Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation. BMC Cardiovas Disorders. 17:238.
   PubMed Web of Science ®Google Scholar
• Pan Y, Abd-Rashid BA, Ismail Z, Ismail R, Mak JW, Pook PC, Er HM, Ong CE. 2011. In vitro determination of the effect of Andrographis paniculata extracts and andrographolide on human hepatic cytochrome P450 activities. J Nat Med. 65:440–447.
   PubMed Web of Science ®Google Scholar
• Patel P, Pandya J, Goldberg M. 2017. NOACs vs. Warfarin for stroke prevention in nonvalvular atrial fibrillation. Cureus. 9:e1395.
   PubMed Web of Science ®Google Scholar
• Pekthong D, Martin H, Abadie C, Bonet A, Heyd B, Mantion G, Richert L. 2008. Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide. J Ethnopharmacol. 115:432–440.
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, Kamali F, Daly AK, Wadelius M. 2015. Oral anticoagulation: a critique of recent advances and controversies. Trends Pharmacol Sci. 36:153–163.
   PubMed Web of Science ®Google Scholar
• Rougee LRA, Mohutsky MA, Bedwell DW, Ruterbories KJ, Hall SD. 2017. The impact of the hepatocyte-to-plasma ph gradient on the prediction of hepatic clearance and drug-drug interactions for CYP2C9 and CYP3A4 substrates. Drug Metab Dispos Biol Fate Chem. 45:1008–1018.
   PubMed Web of Science ®Google Scholar
• Samala S, Veeresham C. 2016. Pharmacokinetic and pharmacodynamic interaction of boswellic acids and andrographolide with glyburide in diabetic rats: including its PK/PD modeling. Phytother Res Ptr. 30:496–502.
   PubMed Web of Science ®Google Scholar
• Tsai HH, Lin HW, Chien CR, Li TC. 2013. Concurrent use of antiplatelets, anticoagulants, or digoxin with Chinese medications: a population-based cohort study. European J Clin Pharmacol. 69:629–639.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang X, Liu F, Wang M, Qin S. 2017. The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism. Pharm Biol. 55:1863–1867.
   PubMed Web of Science ®Google Scholar
• Winkelmayer WC, Liu J, Patrick AR, Setoguchi S, Choudhry NK. 2012. Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis. J Nephrol. 25:341–353.
   PubMed Web of Science ®Google Scholar
• Wu CM, Cao JL, Zheng MH, Ou Y, Zhang L, Zhu XQ, Song JX. 2008. Effect and mechanism of andrographolide on the recovery of Pseudomonas aeruginosa susceptibility to several antibiotics. J Int Med Res. 36:178–186.
   PubMed Web of Science ®Google Scholar
• Xie Y, Ma Y, Xu J, Dan J, Yue P, Wu Z, Yang M, Zheng Q. 2016. Roles of cryo/thermal strength for redispersibility of drug nanocrystals: a representative study with andrographolide. Archives Pharm Res. 39:1404–1417.
   PubMed Web of Science ®Google Scholar
• Yang R, Liu S, Zhou J, Bu S, Zhang J. 2017. Andrographolide attenuates microglia-mediated Aβ neurotoxicity partially through inhibiting NF-κB and JNK MAPK signaling pathway. Immunopharmacol Immunotoxicol. 39:276–284.
   PubMed Web of Science ®Google Scholar
• Yuan H, Sun B, Gao F, Lan M. 2016. Synergistic anticancer effects of andrographolide and paclitaxel against A549 NSCLC cells. Pharm Biol. 54:2629–2635.
   PubMed Web of Science ®Google Scholar
• Zakharyants AA, Burmistrova OA, Poloznikov AA. 2017. The use of human liver cell model and cytochrome p450 substrate-inhibitor panel for studies of dasatinib and warfarin interactions. Bullet Exp Biol Med. 162:515–519.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Huang P, Chen Z, Zheng SW, Yu JY, Shi C. 2017. Clinical application analysis of andrographolide total ester sulfonate injection, a traditional Chinese medicine licensed in China. J Huazhong Univ Sci Technol Med Sci. 37:293–299.
   PubMed Web of Science ®Google Scholar